2 Patents
- US126066032026IL-13 Receptor Alpha 2 Targeted, Zetakine Directed T Cell Immunotherapy
Seattle Children's Hospital
0 cites - US121520792024Nucleic Acids Encoding IL-13 Receptor Alpha 2 (il13ra2) Chimeric Antigen Receptor for Tumor Specific T Cell Immunotherapy
Seattle Children's Research Institute
0 cites